All reactive primary HIV test results (eg. rapid tests) must be confirmed with a confirmatory test in the laboratory.
All reactive primary HIV test results (e.g. rapid tests) must be confirmed with a confirmatory test in the laboratory (see "testing flow chart" Figure in previous section). HIV antibody assays typically have exceptionally high sensitivity and specificity compared with those of assays for other infectious diseases. That being the case, there is generally a trade-off that favours sensitivity over specificity for the primary HIV assay so as not to miss true positive specimens. Additional testing is required to resolve cases of false reactivity (that is, to rule out false positives) and to verify reactivity (that is, to rule in true positives).
RETESTING IS NOT RECOMMENDED FOR INDIVIDUALS ON ART.
IT IS RECOMMENDED THAT PEOPLE WHO INJECT DRUGS BE RETESTED WITHIN SIX MONTHS.
A negative result means either that person tested do not have HIV infection and can not transmit HIV infection to others or that too short time has elapsed from the infection and antibodies have not yet developed (less than 3 months). In the latter case, the person can transmit the infection to others. A negative antibody result does not mean that the person is immune to infection.
A primary HIV-antibody positive result means that a confirmatory test should be done to make sure that the screening test result was correct. If the confirmatory test is also positive, it means that the person has HIV infection and can transmit HIV infection to others. People living with HIV are at risk to develop AIDS or other HIV related complications if they do not start ARV treatment.